Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
about
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trialsThe pandemic influenza A (H1N1) 2009 vaccine does not increase the mortality rate of idiopathic interstitial pneumonia: a matched case-control study.Inspecting the Mechanism: A Longitudinal Analysis of Socioeconomic Status Differences in Perceived Influenza Risks, Vaccination Intentions, and Vaccination Behaviors during the 2009-2010 Influenza PandemicRefining the approach to vaccines against influenza A viruses with pandemic potential.The swine flu vaccine, public attitudes, and researcher interpretations: a systematic review of qualitative research.The impact of sex, gender and pregnancy on 2009 H1N1 diseaseThe first influenza pandemic of the new millennium.Immunogenicity and safety of pandemic influenza A (H1N1) 2009 vaccine: systematic review and meta-analysis.Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent VaccinesThe neuropsychiatric aspects of influenza/swine flu: A selective review.Possible life-threatening adverse reaction to monovalent H1N1 vaccineImmunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in an immunocompromised population: a prospective study comparing HIV-infected adults with HIV-uninfected adultsThe UK immunisation schedule: changes to vaccine policy and practice in 2013/14Effect of Broccoli Sprouts and Live Attenuated Influenza Virus on Peripheral Blood Natural Killer Cells: A Randomized, Double-Blind Study.Hospital discharge data for Guillain-Barré syndrome and influenza A (H1N1) vaccine adverse events
P2860
Q26799634-8945E97D-B5C3-4643-9835-653D499F0CEFQ28748654-50DD8762-D249-4864-ACD1-CCEECF4D9D96Q30359671-C38BBB6D-4B94-4316-86A5-9DC18A8D3D2EQ30379687-CC4C6ECC-9AD1-48BA-9049-14DF089350AAQ30381595-E3E348A5-E4CA-45AE-941D-8788E65988E5Q30389706-766C76CD-4E2A-4679-A05B-722E56FAC185Q30398193-B6B48F0E-213A-4319-A438-7A8513A07C40Q30401658-A6F7B262-B749-4EE3-9816-B74C06410627Q30403801-E385E449-A644-4F4D-B3DF-EE7FF8AC6674Q30420816-8E690E35-0B65-466B-B5BA-3AB1215DCDB4Q30425173-E9B0FDEC-4720-4A1B-A0E4-A5D1684C43B4Q34026862-6D144B5D-9074-4544-808B-6A5E3DC53230Q34699094-E38CA550-7E80-4BB0-A58C-58EA2CE7C451Q35598447-29BE4E46-A9FF-4CE2-8273-1A07953C28B5Q35906978-46047063-33D2-4B84-BAE6-94903C7CC1D4Q42598383-4955A200-8BDF-4ABC-A3CB-92FC04F60A75
P2860
Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Safety of influenza A (H1N1) 2 ...... , October 1-November 24, 2009.
@ast
Safety of influenza A (H1N1) 2 ...... , October 1-November 24, 2009.
@en
Safety of influenza A (H1N1) 2 ...... , October 1-November 24, 2009.
@nl
type
label
Safety of influenza A (H1N1) 2 ...... , October 1-November 24, 2009.
@ast
Safety of influenza A (H1N1) 2 ...... , October 1-November 24, 2009.
@en
Safety of influenza A (H1N1) 2 ...... , October 1-November 24, 2009.
@nl
prefLabel
Safety of influenza A (H1N1) 2 ...... , October 1-November 24, 2009.
@ast
Safety of influenza A (H1N1) 2 ...... , October 1-November 24, 2009.
@en
Safety of influenza A (H1N1) 2 ...... , October 1-November 24, 2009.
@nl
P1476
Safety of influenza A (H1N1) 2 ...... s, October 1-November 24, 2009
@en
P304
P577
2009-12-01T00:00:00Z